26.04.2016
- Novartis is said to be planning to divest its nearly $14 billion stake in rival Swiss drugmaker Roche, accounting for about 6% of that company’s shares and more than 30% of its...
01.04.2016
- An anonymous whistleblower has accused Swiss drugmaker Novartis of paying bribes in Turkey through a consulting firm to secure business advantages worth an estimated $85 million...
28.10.2015
- Novartis has agreed to pay $390 million to settle with the US Department of Justice over allegations it used kickbacks to specialist pharmacies to promote sales of some of its...
07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
13.03.2015
- Both European and US pharmaceutical industry players are highly research-oriented and possess very diversified portfolios. While each country has its national champions, Swiss...
08.05.2014
- In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...
12.02.2013
- For pharmaceutical companies, Africa is changing. Not only is the continent's economic growth grabbing attention in boardrooms but the shifting nature of its disease burden is...
25.01.2013
- Novartis Chief Executive Joe Jimenez played down talk that it was looking to sell its one-third voting stake in crosstown rival Roche, and certainly not at its current market price...
